A multimarker approach to diagnose and stratify heart failure.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Cardiology

• Publication date

  2015-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2014.12.052PMID 25555282
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review

  2014cited by this paper
• Plasma level of N-terminal pro brain natriuretic peptide (NT-proBNP) in elderly population in Poland--the PolSenior Study.

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• Biomarkers and diagnostics in heart failure.

  2013cited by this paper
• Analytical characterization and clinical evaluation of an enzyme-linked immunosorbent assay for measurement of afamin in human plasma☆

  2013cited by this paper
• Focused Update : ACCF / AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults

  2013cited by this paper
• Circulating fragments of N-terminal pro-B-type natriuretic peptides in plasma of heart failure patients.

  2013influential reference
• Depletion of proBNP1-108 in Patients with Heart Failure Prevents Cross-Reactivity with Natriuretic Peptides

  2013cited by this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

  2012cited by this paper
• Validation and quality control of ELISAs for the use with human saliva samples.

  2012cited by this paper
• Circulating forms of the b-type natriuretic peptide prohormone: pathophysiologic and clinical considerations.

  2012cited by this paper
• Japanese-Western consensus meeting on biomarkers.

  2011cited by this paper
• The effect of glycosylation on plasma N-terminal proBNP-76 levels in patients with heart or renal failure

  2011cited by this paper
• Global status report on noncommunicable diseases 2010.

  2011cited by this paper
• One-step homogeneous C-reactive protein assay for saliva.

  2011cited by this paper
• Comparison of Mass Spectrometry and Clinical Assay Measurements of Circulating Fragments of B-Type Natriuretic Peptide in Patients With Chronic Heart Failure

  2011cited by this paper
• Pro-B-type natriuretic peptide(1-108) circulates in the general community: plasma determinants and detection of left ventricular dysfunction.

  2011cited by this paper
• Simultaneous Assessment of Unprocessed ProBNP1-108 in Addition to Processed BNP32 Improves Identification of High-Risk Ambulatory Patients With Heart Failure

  2010cited by this paper
• Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases.

  2010cited by this paper
• Diversity of molecular forms of plasma brain natriuretic peptide in heart failure—different proBNP-108 to BNP-32 ratios in atrial and ventricular overload

  2009cited by this paper
• Amino-terminal pro-B-type natriuretic peptide: analytic considerations.

  2008cited by this paper
• Pro-B-type natriuretic peptide levels in acute decompensated heart failure.

  2008cited by this paper
• Limit of blank, limit of detection and limit of quantitation.

  2008cited by this paper
• Immunodetection of glycosylated NT-proBNP circulating in human blood.

  2008cited by this paper
• Et al

  2008cited by this paper
• Stability of analytes in biosamples—an important issue in clinical and forensic toxicology?

  2007cited by this paper
• The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure.

  2007cited by this paper
• The precursor to B-type natriuretic peptide is an O-linked glycoprotein.

  2006cited by this paper
• Quality specifications for B-type natriuretic peptide assays.

  2005cited by this paper
• Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

  2005cited by this paper
• Single assay for amino-terminal fragments of cardiac A- and B-type natriuretic peptides.

  2005cited by this paper
• Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine

  2005cited by this paper
• Standardization of Cardiac Markers

  2005cited by this paper
• Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review.

  2004cited by this paper
• Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides.

  2004cited by this paper
• Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited.

  2004cited by this paper
• Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease.

  2004cited by this paper
• Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.

  2003cited by this paper
• Characterization of molecular forms of probrain natriuretic peptide in human plasma.

  2003cited by this paper
• Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study.

  2001cited by this paper
• The role of the circulation in processing pro-brain natriuretic peptide (proBNP) to amino-terminal BNP and BNP-32.

  1997cited by this paper
• The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma.

  1995cited by this paper
• Multivariate receiver-operating characteristic curve analysis: prostate cancer screening as an example.

  1995cited by this paper
• Generation and application of data on biological variation in clinical chemistry.

  1989cited by this paper

• Improvement initiatives in the diagnostic process of heart failure: a scoping review

  2026influential citation
• Salivary Proteome Is Altered in Children With Small Area Thermal Burns

  2025cites this paper
• Prognostic utility of serum NT-proBNP (fragments 1-76aa and 13-71aa) and galectin-3 in predicting death and re-hospitalisation due to cardiovascular events in patients with heart failure

  2023cites this paper
• Diagnosis of septic shock by serum measurement of human neutrophil lipocalin by a rapid homogeneous assay.

  2023cites this paper
• A rapid and accurate method for screening T-2 toxin in food and feed using competitive AlphaLISA.

  2021cites this paper
• Identification and Validation of a Salivary Protein Panel to Detect Heart Failure Early

  2017cites this paper
• AlphaScreen-Based Assays: Ultra-High-Throughput Screening for Small-Molecule Inhibitors of Challenging Enzymes and Protein-Protein Interactions.

  2016cites this paper
• Role of matrix metalloproteinase-9 in chronic kidney disease: a new biomarker of resistant albuminuria.

  2016cites this paper